Today’s issue of WorkCompRecap features the release of a new FlashReport from WCRI that examines how a Texas-like closed formulary might affect the prevalence and costs of drugs prescribed to Louisiana state employees.
This particular report does not study the impact of a drug formulary on patient outcomes and overall medical costs or estimate the potential cost savings for all workers’ comp claims in the state. It instead provides a broad range of estimates that depend on different assumptions regarding provider behavior. Key items addressed include how frequently non-formulary drugs that require preauthorization under the Texas closed formulary are prescribed to Louisiana state employees, and what the most frequently prescribed non-formulary drugs are; the proportion of the prescription costs from non-formulary drugs; and the potential prescription cost savings that would arise if a Texas-like closed formulary is implemented.
Find out more by clicking here!